Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk
Anita Villani, Mary‐Louise C. Greer, Jennifer M. Kalish, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 12, pp. e83-e90
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma
Jennifer M. Kalish, Leslie Doros, Lee J. Helman, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 13, pp. e115-e122
Open Access | Times Cited: 175
Growth Hormone’s Links to Cancer
César Luiz Boguszewski, Margaret Cristina da Silva Boguszewski
Endocrine Reviews (2018) Vol. 40, Iss. 2, pp. 558-574
Open Access | Times Cited: 126
Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births
Philip J. Lupo, Jeremy M. Schraw, Tania A. Desrosiers, et al.
JAMA Oncology (2019) Vol. 5, Iss. 8, pp. 1150-1150
Open Access | Times Cited: 125
Costello syndrome: Clinical phenotype, genotype, and management guidelines
Karen W. Gripp, Lindsey A. Morse, Marni E. Axelrad, et al.
American Journal of Medical Genetics Part A (2019) Vol. 179, Iss. 9, pp. 1725-1744
Open Access | Times Cited: 110
Overgrowth syndromes — clinical and molecular aspects and tumour risk
Frédéric Brioude, Annick Toutain, Éloïse Giabicani, et al.
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 5, pp. 299-311
Closed Access | Times Cited: 87
Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum
Marialetizia Motta, Luca Pannone, Francesca Pantaleoni, et al.
The American Journal of Human Genetics (2020) Vol. 107, Iss. 3, pp. 499-513
Open Access | Times Cited: 75
Clinical overview on RASopathies
Martin Zenker
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 414-424
Open Access | Times Cited: 51
Diagnostic Approach to Macrocephaly in Children
Andrea Accogli, Ana Filipa Geraldo, Gianluca Piccolo, et al.
Frontiers in Pediatrics (2022) Vol. 9
Open Access | Times Cited: 39
Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1–PPP1CB complexes
Ikumi Umeki, Tetsuya Niihori, Taiki Abe, et al.
Human Genetics (2018) Vol. 138, Iss. 1, pp. 21-35
Closed Access | Times Cited: 71
JMML genomics and decisions
Charlotte M. Niemeyer
Hematology (2018) Vol. 2018, Iss. 1, pp. 307-312
Open Access | Times Cited: 67
Cancer‐related mortality among people with intellectual disabilities: A nationwide population‐based cohort study
Maarten Cuypers, Bianca W. M. Schalk, Anne J. N. Boonman, et al.
Cancer (2021) Vol. 128, Iss. 6, pp. 1267-1274
Open Access | Times Cited: 51
Advancing RAS/RASopathy therapies: An NCI‐sponsored intramural and extramural collaboration for the study of RASopathies
Andrea M. Gross, Megan N. Frone, Karen W. Gripp, et al.
American Journal of Medical Genetics Part A (2020) Vol. 182, Iss. 4, pp. 866-876
Open Access | Times Cited: 50
Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
Tadashi Kumamoto, Fumito Yamazaki, Yoshiko Nakano, et al.
International Journal of Clinical Oncology (2021) Vol. 26, Iss. 12, pp. 2161-2178
Open Access | Times Cited: 46
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies
Melissa R. Perrino, Anirban Das, Sarah Scollon, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 21, pp. 4834-4843
Closed Access | Times Cited: 6
De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism
Illja J. Diets, Roos van der Donk, Kristina Baltrunaite, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 4, pp. 758-766
Open Access | Times Cited: 43
Lymphatic Abnormalities in Noonan Syndrome Spectrum Disorders: A Systematic Review
Julia Sleutjes, Lotte E. R. Kleimeier, Erika Leenders, et al.
Molecular Syndromology (2021) Vol. 13, Iss. 1, pp. 1-11
Open Access | Times Cited: 34
Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome
Jovanna Dahlgren, C. Noordam
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 2034-2034
Open Access | Times Cited: 25
Defining the variant-phenotype correlation in patients affected by Noonan syndrome with the RAF1:c.770C>T p.(Ser257Leu) variant
Andrea Gazzin, Federico Fornari, Marcello Niceta, et al.
European Journal of Human Genetics (2024) Vol. 32, Iss. 8, pp. 964-971
Closed Access | Times Cited: 5
Neuroblastoma Predisposition and Surveillance—An Update from the 2023 AACR Childhood Cancer Predisposition Workshop
Junne Kamihara, Lisa Diller, William D. Foulkes, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 15, pp. 3137-3143
Open Access | Times Cited: 5
Is MRI imaging in pediatric age totally safe? A critical reprisal
Sergio Salerno, Claudio Granata, Marco Trapenese, et al.
La radiologia medica (2018) Vol. 123, Iss. 9, pp. 695-702
Open Access | Times Cited: 41
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice
Margaret Cristina da Silva Boguszewski, Adriane Cardoso-Demartini, César Luiz Boguszewski, et al.
Pituitary (2021) Vol. 24, Iss. 5, pp. 810-827
Open Access | Times Cited: 31
Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review
G.J. Reynolds, Andrea Gazzin, Diana Carli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3515-3515
Open Access
Advances in neuroblastoma therapy
Suzanne P. MacFarland, Rochelle Bagatell
Current Opinion in Pediatrics (2018) Vol. 31, Iss. 1, pp. 14-20
Closed Access | Times Cited: 34
De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies
Daniel Fritzen, Alma Kuechler, Mona Grimmel, et al.
Human Genetics (2018) Vol. 137, Iss. 5, pp. 401-411
Closed Access | Times Cited: 33
Low-Grade Gliomas in Patients with Noonan Syndrome: Case-Based Review of the Literature
Mariachiara Lodi, Luigi Boccuto, Andrea Carai, et al.
Diagnostics (2020) Vol. 10, Iss. 8, pp. 582-582
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top